Optical coherence tomography-based ranibizumab monotherapy for retinal angiomatous proliferation in Korean patients.
*Department of Ophthalmology, Seoul National University Hospital, Seoul, South Korea; and †Sensory Organs Institute, Medical Research Center, Seoul National University, Seoul, South Korea.
- Published Article
Retina (Philadelphia, Pa.)
- Publication Date
Dec 01, 2014
Retinal angiomatous proliferation may be successfully managed with ranibizumab monotherapy in Korean patients, with the number of treatments required comparable to other forms of neovascular age-related macular degeneration. However, visual improvement was limited in late-stage RAP.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 04/18/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/25011025